Analgesia Nociception Index in Orthognathic Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Analgesia/Nociception Index (ANI) monitoring: intraoperative analgesia was provided by infusion of remifentanil via target controlled infusion mode, which was controlled according to ANI monitor.
Standard monitoring: intraoperative analgesia was provided by infusion of remifentanil via target controlled infusion mode, which was controlled according to the clinician's decision
Study summary
This study aims to determine whether goal-directed analgesia using ANI(Analgesia/Nociception Index) can improve the quality of postoperative recovery in patients undergoing maxillofacial surgery.
Eligibility
Primary outcome measure(s)
- Postoperative QoR-15K score — 24 hours after the end of surgery
Korean-translated QoR-15K (15-item Quality of Recovery (QoR-15) scale, minimum 0, maximum 150, higher scores mean a better outcome ) scores assessed by participants blinded to arm assignment 24 hours after surgery.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Seoul National University Children's Hospital | Seoul | South Korea | Recruiting |
More Seoul National University Hospital trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06205355 on ClinicalTrials.gov ↗ ← All trials in South Korea